Clinical Trial Update: APPROPRIATE - Rate Adaptive Pacing Sensor [NA]

View source ↗

Summary

The APPROPRIATE trial evaluating a rate-adaptive pacing sensor for heart disease was terminated, and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Heart Diseases | NA | Status: TERMINATED | Results posted: 2017-06-14